Sources say FDA commissioner sought rejection of KalVista’s rare disease drug; FDA looks into Sarepta’s Duchenne therapy after deaths; and more
Article Title: “Sources Say FDA Commissioner Sought Rejection of KalVista’s Rare Disease Drug; FDA Looks into Sarepta’s Duchenne Therapy after Deaths; and More” Publication Date: June 28, 2025 Endpoints News reported on June 28, 2025 that the FDA Commissioner pursued…